Cargando…
Model consent clauses for rare disease research
BACKGROUND: Rare Disease research has seen tremendous advancements over the last decades, with the development of new technologies, various global collaborative efforts and improved data sharing. To maximize the impact of and to further build on these developments, there is a need for model consent...
Autores principales: | Nguyen, Minh Thu, Goldblatt, Jack, Isasi, Rosario, Jagut, Marlene, Jonker, Anneliene Hechtelt, Kaufmann, Petra, Ouillade, Laetitia, Molnar-Gabor, Fruszina, Shabani, Mahsa, Sid, Eric, Tassé, Anne Marie, Wong-Rieger, Durhane, Knoppers, Bartha Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676617/ https://www.ncbi.nlm.nih.gov/pubmed/31370847 http://dx.doi.org/10.1186/s12910-019-0390-x |
Ejemplares similares
-
Bridging consent: from toll bridges to lift bridges?
por: Budin-Ljøsne, Isabelle, et al.
Publicado: (2011) -
How to START? Four pillars to optimally begin your orphan drug development
por: Jonker, Anneliene Hechtelt, et al.
Publicado: (2023) -
Harmonised consent in international research consortia: an impossible dream?
por: Wallace, Susan E., et al.
Publicado: (2011) -
From the principles of genomic data sharing to the practices of data access committees
por: Shabani, Mahsa, et al.
Publicado: (2015) -
From Banking to International Governance: Fostering Innovation in Stem Cell Research
por: Isasi, Rosario, et al.
Publicado: (2011)